Search - tctmd.com

Displaying 81 - 100 of 227

Sort: Relevancy | Date

News Daily News

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

L.A. McKeown

July 01, 2015

News Daily News

RIBS IV：EES 支架内再狭窄治疗效果超越 DCB

L.A. McKeown

July 01, 2015

News Daily News

LEVANT 2: Un BRF Supera a la Angioplastia con Balón Estándar al cabo de 1 Año en el Manejo de la Enfermedad Femoropoplítea

Yael L. Maxwell

June 26, 2015

News Daily News

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

Yael L. Maxwell

June 26, 2015

News Daily News

LEVANT 2：DCB 治疗股腘动脉疾病的 1 年随访结果优于标准球囊成形术

Yael L. Maxwell

June 26, 2015

News Industry News

The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA

June 25, 2015

News Daily News

Stenting Provides Better Early Outcomes vs Angioplasty Alone for PAD

Todd Neale

June 08, 2015

News Daily News

ISAR-DESIRE 3: Un Balón Recubierto de Fármaco Confiere un Efecto Reestenótico Duradero en la Reestenosis del SLF

L.A. McKeown

June 03, 2015

News Daily News

ISAR-DESIRE 3: Drug-Coated Balloon Shows Durable Antirestenotic Effect in DES Restenosis

L.A. McKeown

June 03, 2015

News Daily News

ISAR-DESIRE 3：药物涂层球囊对 DES 再狭窄表现出持续抗再狭窄效应

L.A. McKeown

June 03, 2015

News Conference News EuroPCR 2015

Studies Provide Encouraging Results for DCB in Long SFA Lesions

Caitlin E. Cox

May 22, 2015

News Industry News

QT Vascular Announces First Patients Enrolled In Clinical Study Of Chocolate Touch™ PTCA Coronary Drug-Coated Balloon

May 20, 2015

News Industry News

BIOTRONIK Announces European Launch of Pantera Pro Coronary Balloon Catheter

April 01, 2015

News Daily News

Los BRF son Equiparables a los SLF en el Tratamiento de Pacientes ‘del Mundo Real’ con Reestenosis Intra-Stent

March 04, 2015

News Daily News

DCB与DES的“真实”支架内再狭窄患者治疗效果相当

March 04, 2015

News Daily News

DCB Matches DES in Treating ‘Real-World’ Patients With In-Stent Restenosis

March 04, 2015

News Industry News

Boston Scientific And C. R. Bard Announce Distribution Agreement For Lutonix® Drug Coated Balloon

February 08, 2015

News Daily News

ISET Abstracts Shed Light on Novel Therapies for PAD

Caitlin E. Cox

February 04, 2015

Presentation ISET 2015

Drug-Coated Balloons: How Does It Change the Treatment Landscape for CLI?

Presenter: Thomas Zeller

February 03, 2015

News Daily News

TE-PROVE: European Postapproval Study of PES Shows Safety in All-Comers

Yael L. Maxwell

January 28, 2015

Advertisement

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

RIBS IV：EES 支架内再狭窄治疗效果超越 DCB

LEVANT 2: Un BRF Supera a la Angioplastia con Balón Estándar al cabo de 1 Año en el Manejo de la Enfermedad Femoropoplítea

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

LEVANT 2：DCB 治疗股腘动脉疾病的 1 年随访结果优于标准球囊成形术

The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA

Stenting Provides Better Early Outcomes vs Angioplasty Alone for PAD

ISAR-DESIRE 3: Un Balón Recubierto de Fármaco Confiere un Efecto Reestenótico Duradero en la Reestenosis del SLF

ISAR-DESIRE 3: Drug-Coated Balloon Shows Durable Antirestenotic Effect in DES Restenosis

ISAR-DESIRE 3：药物涂层球囊对 DES 再狭窄表现出持续抗再狭窄效应

Studies Provide Encouraging Results for DCB in Long SFA Lesions

QT Vascular Announces First Patients Enrolled In Clinical Study Of Chocolate Touch™ PTCA Coronary Drug-Coated Balloon

BIOTRONIK Announces European Launch of Pantera Pro Coronary Balloon Catheter

Los BRF son Equiparables a los SLF en el Tratamiento de Pacientes ‘del Mundo Real’ con Reestenosis Intra-Stent

DCB与DES的“真实”支架内再狭窄患者治疗效果相当

DCB Matches DES in Treating ‘Real-World’ Patients With In-Stent Restenosis

Boston Scientific And C. R. Bard Announce Distribution Agreement For Lutonix® Drug Coated Balloon

ISET Abstracts Shed Light on Novel Therapies for PAD

Drug-Coated Balloons: How Does It Change the Treatment Landscape for CLI?

TE-PROVE: European Postapproval Study of PES Shows Safety in All-Comers

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content